School of Medicine
Showing 21-30 of 37 Results
-
Adina S. Fischer, MD, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.
Dr. Fischer’s translational program of research focuses on:
(1) Improving our understanding of protective biomarkers of resilience to depression
(2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
(3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use
Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences. -
Jelle Folkerts
Postdoctoral Scholar, Pathology
BioDr. Folkerts received his master's degree in Drug Innovation from Utrecht University in the Netherlands, during which he spent a year at the Galli lab at Stanford on a Fulbright Scholarship. During this time, Dr. Folkerts played a key role in developing a technology platform employing functional genomics and high-resolution single-cell confocal imaging, enabling the rapid identification of degranulation regulators in primary human mast cells. Following his time at Stanford, Dr. Folkerts studied the regulatory mechanisms of human mast cell activation under the guidance of Rudi Hendriks and Marcus Maurer, earning his Ph.D. in 2022. He then returned to Stanford as a postdoctoral fellow in the Galli lab, where his current research focuses on the identification of human mast cell degranulation regulators using a whole-genome CRISPR knockout library screen, and the validation of these findings using the recently developed technology platform. It is his long-standing goal to contribute to the design and development of specific and effective therapeutic interventions for mast cell-mediated diseases.
-
Daiana Fornes
Postdoctoral Scholar, Pulmonary
BioDaiana Fornes is a postdoctoral scholar at Stanford University, supported by a Maternal & Child Health Research Institute (MCHRI) Postdoctoral Fellowship. Her research centers on reproductive biology and pregnancy disorders, with a particular focus on uterine contractility, preterm labor, and uterine atony. She investigates calcium signaling pathways, including the role of TRPV4 ion channels, to identify novel therapeutic strategies aimed at improving maternal health outcomes.
Daiana earned her PhD from the University of Buenos Aires, where she studied metabolic alterations during pregnancy and their effects on fetal development. Her training has provided her with a strong foundation in translational research, with extensive experience in experimental design, molecular biology, and the analysis of signaling pathways. -
Ines Forrest
Postdoctoral Scholar, Stanford Cancer Institute
BioI completed a dual Master's Degree in Chemistry/Biochemistry (University of Oklahoma) and Organic Chemistry/Chemical Engineering (Sigma-Clermont), as well as a Ph.D. in Chemical and Biological Sciences (The Scripps Research Institute). As a postdoctoral research fellow at Stanford in Prof. Nathanael Gray's lab, I look forward to applying my skills in chemical proteomics, chemistry, and molecular biology to drive impactful research at the interface of chemistry and medicine and develop pioneering solutions to improve human health.
-
Jenna Forsyth
Director, Project Unleaded, Human and Planetary Health
BioJenna Forsyth, PhD, is an interdisciplinary environmental health scientist. She has focused on lead exposure research for 10 years and currently oversees the research portfolio for Project Unleaded - an initiative to identify and mitigate priority sources of lead poisoning globally, with an emphasis in South Asia. Based on her team’s discovery and effort to address lead poisoning from turmeric in Bangladesh, she was named one of the 100 most influential people in Global Health by Time Magazine in 2024. Prior to studying lead contamination and poisoning, she spent nearly 10 years addressing global and environmental health problems from contaminants in the air, water, soil, and food. Her work has been featured in The Economist, The Washington Post, Vox, The Scientist, Undark, Think Global Health, Environmental Health News, Stanford Medicine, Effective Altruism and other outlets. She holds a PhD in Environment and Resources from Stanford University and a Master’s of Science in Engineering and Certificate in Global Health from the University of Washington.
